Related Experiment Videos
Phenotypic variability associated with 14 splice-site mutations in the NF2 gene
L Kluwe1, M MacCollin, M Tatagiba
1Department of Neurosurgery, University Hospital Eppendorf, Hamburg, Germany. kluwe@uke.uni-hamburg.de
American Journal of Medical Genetics
|May 30, 1998
Summary
Splice-site mutations in the NF2 gene are a common cause of Neurofibromatosis type 2 (NF2). These mutations lead to varied clinical outcomes, from severe symptoms to being asymptomatic, highlighting genotype-phenotype variability.
Area of Science:
- Genetics
- Oncology
- Neurology
Background:
- Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder.
- NF2 is characterized by predisposition to tumors, notably bilateral vestibular schwannomas.
- Mutations in the NF2 gene are the underlying cause of the disorder.
Purpose of the Study:
- To investigate the spectrum of phenotypes associated with splice-site mutations in the NF2 gene.
- To explore the correlation between specific splice-site mutation locations and clinical presentation in NF2 patients.
- To assess the frequency of splice-site alterations as a cause of NF2.
Main Methods:
- Screening of 87 unrelated NF2 patients for NF2 gene mutations.
- Utilizing single strand conformation polymorphism and temperature gradient gel electrophoresis.
- Analysis of phenotypes in 14 patients and 11 relatives carrying identified splice-site mutations.
Main Results:
- Identified 14 distinct splice-site mutations in the NF2 gene across 25 individuals (14 propositi, 11 relatives).
- Mutations were found in various exons (2, 3, 5, 7, 8, 14, 15), associated with a wide range of phenotypes.
- Mutations downstream from exon 8 were more frequently linked to milder phenotypes; no meningiomas observed with mutations in exons 14 and 15.
Conclusions:
- Splice-site alterations represent a significant and common cause of NF2.
- Clinical outcomes of NF2 patients with splice-site mutations exhibit considerable variability, even within families.
- These findings contribute to understanding genotype-phenotype correlations in Neurofibromatosis type 2.